Last reviewed · How we verify
Sasapyrine — Competitive Intelligence Brief
discontinued
salsalate
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
Sasapyrine (SALSALATE). Salsalate works by inhibiting the enzyme COX-1 and COX-2, which are responsible for producing prostaglandins.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sasapyrine TARGET | SALSALATE | discontinued | salsalate |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (salsalate class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sasapyrine CI watch — RSS
- Sasapyrine CI watch — Atom
- Sasapyrine CI watch — JSON
- Sasapyrine alone — RSS
- Whole salsalate class — RSS
Cite this brief
Drug Landscape (2026). Sasapyrine — Competitive Intelligence Brief. https://druglandscape.com/ci/salsalate. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab